A Four Week, Open-Label Study of Azithromycin Ophthalmic Solution, 1% (P08641)

Clinical trial NCT01220258 · TERMINATED

Trial details

NCT number: NCT01220258
Sponsor: Merck Sharp & Dohme LLC
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Posterior Blepharoconjunctivitis

Start date: 2010-11-01
Primary completion: 2011-08-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.